SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Abbott Laboratories and Enanta Pharmaceuticals, Inc. Present Positive Initial Results from Phase 2 Study of ABT-450/r for Treatment of Hepatitis C